IceCure Medical (ICCM) Cash from Investing Activities (2025 - 2026)

IceCure Medical (ICCM) reported Cash from Investing Activities of -$51000.0 for Q1 2026, down 750.0% year-over-year from $7846.2 in Q1 2025, and down 750.0% on a QoQ basis from -$6000.0 in Q1 2025.

IceCure Medical (ICCM) has 2 years of Cash from Investing Activities data on file, last reported at -$51000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.32 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -185.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.50 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -217.20 Mn
10 IceCure Medical 12.09 -8.11 Mn 295,000.00 -51,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -51,000.00
Mar 31, 2026 -51,000.00
Mar 31, 2025 -6,000.00
Mar 31, 2025 -6,000.00